Moderna says bivalent booster performs better against BA.5 omicron subvariant

Moderna released data from a Phase 2-3 clinical trial showing its bivalent COVID-19 booster shot performed better against the BA.4 and BA.5 omicron subvariants.

from ABC News: Top Stories https://ift.tt/rAVSfn6
via IFTTT